As of 2025-06-20, the Intrinsic Value of Sicagen India Ltd (SICAGEN.NS) is 17.17 INR. This SICAGEN.NS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 24.60 INR, the upside of Sicagen India Ltd is -30.20%.
The range of the Intrinsic Value is 9.78 - 29.32 INR
Based on its market price of 24.60 INR and our intrinsic valuation, Sicagen India Ltd (SICAGEN.NS) is overvalued by 30.20%.
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | 9.78 - 29.32 | 17.17 | -30.2% |
DCF (Growth 10y) | 8.63 - 24.46 | 14.71 | -40.2% |
DCF (EBITDA 5y) | 18.00 - 64.65 | 38.47 | 56.4% |
DCF (EBITDA 10y) | 15.78 - 54.38 | 31.97 | 30.0% |
Fair Value | 112.59 - 112.59 | 112.59 | 357.66% |
P/E | 38.55 - 82.50 | 63.21 | 156.9% |
EV/EBITDA | 23.23 - 83.78 | 64.22 | 161.0% |
EPV | 34.42 - 50.46 | 42.44 | 72.5% |
DDM - Stable | 16.23 - 29.38 | 22.80 | -7.3% |
DDM - Multi | 12.88 - 18.57 | 15.24 | -38.0% |
Market Cap (mil) | 973.42 |
Beta | |
Outstanding shares (mil) | 39.57 |
Enterprise Value (mil) | 1,897.32 |
Market risk premium | 8.83% |
Cost of Equity | 18.61% |
Cost of Debt | 9.35% |
WACC | 11.92% |